These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11493453)

  • 21. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation.
    Gallegos AM; Bevan MJ
    J Exp Med; 2004 Oct; 200(8):1039-49. PubMed ID: 15492126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes.
    Joffre O; Gorsse N; Romagnoli P; Hudrisier D; van Meerwijk JP
    Blood; 2004 Jun; 103(11):4216-21. PubMed ID: 14976053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
    Turley DM; Miller SD
    J Immunol; 2007 Feb; 178(4):2212-20. PubMed ID: 17277126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.
    Chung JB; Wells AD; Adler S; Jacob A; Turka LA; Monroe JG
    J Immunol; 2003 Aug; 171(4):1758-67. PubMed ID: 12902475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta.
    Lan F; Zeng D; Huie P; Higgins JP; Strober S
    Blood; 2001 Jun; 97(11):3458-65. PubMed ID: 11369637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL.
    Nelson DJ; Mukherjee S; Bundell C; Fisher S; van Hagen D; Robinson B
    J Immunol; 2001 May; 166(9):5557-66. PubMed ID: 11313395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy.
    Egan RM; Yorkey C; Black R; Loh WK; Stevens JL; Storozynsky E; Lord EM; Frelinger JG; Woodward JG
    J Immunol; 2000 May; 164(9):4543-50. PubMed ID: 10779755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral CD4(+) T-cell tolerance is induced in vivo by rare antigen-bearing B cells in follicular, marginal zone, and B-1 subsets.
    Murray SE; Toren KG; Parker DC
    Eur J Immunol; 2013 Jul; 43(7):1818-27. PubMed ID: 23532986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.
    Albert ML; Jegathesan M; Darnell RB
    Nat Immunol; 2001 Nov; 2(11):1010-7. PubMed ID: 11590405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathymic and extrathymic tolerance in bone marrow chimeras.
    Sprent J; Kosaka H; Gao EK; Surh CD; Webb SR
    Immunol Rev; 1993 Jun; 133():151-76. PubMed ID: 8225365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole lymphoma B cells allow efficient cross-presentation of antigens by dendritic cells.
    Manches O; Lui G; Molens JP; Sotto JJ; Chaperot L; Plumas J
    Cytotherapy; 2008; 10(6):642-9. PubMed ID: 18836919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.
    Richards DM; Dalheimer SL; Ehst BD; Vanasek TL; Jenkins MK; Hertz MI; Mueller DL
    J Immunol; 2004 Mar; 172(6):3469-79. PubMed ID: 15004147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-reactive memory T cells from bone marrow: Spontaneous induction and therapeutic potential (Review).
    Schirrmacher V
    Int J Oncol; 2015 Dec; 47(6):2005-16. PubMed ID: 26459860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.